Skip to content

Acoustic Speech Measurement Synchronous Facial and Laryngeal Surface EMG Signal Acquisition and Analysis in Patients with Post-stroke Neurological Speech Disorder

Acoustic Speech Measurement Synchronous Facial and Laryngeal Surface EMG Signal Acquisition and Analysis in Patients with Post-stroke Neurological Speech Disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098519
Enrollment
Unknown
Registered
2025-03-10
Start date
2024-12-11
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysarthria after stroke

Interventions

Case group:None
Health control group:None

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Case Group Inclusion Criteria: 1. Stroke was diagnosed according to CT or MRI of the brain, and the diagnosis was based on the Key Points for the Diagnosis of Major Cerebrovascular Diseases in China 2019; 2. Age 30-80 years; 3. Clear, stable general condition, no obvious hearing abnormalities, no severe cognitive dysfunction, Concise Mental State Checklist MMSE score >=10 points, can cooperate with speech assessment; 4. Able to communicate in Mandarin Chinese; 5. Diagnosis of neurological speech disorder (clinically often referred to as dysarthria) by an experienced speech therapist through the Frenchay dysarthria; 6. Normal speech function before the onset of the disease, and no organic diseases affecting the voice. 7. Agree to participate in the study and sign the informed consent form. The control group selected normal adults who matched the gender and age of the experimental group, and the enrollment criteria were: they could communicate in Mandarin Chinese, and had a primary school education level or above; There is no history of vocal cord nodules, vocal cord polyps, laryngeal puffs and other voice diseases; There is no history of neurodegenerative diseases such as Parkinson's disease, amyotrophic lateral sclerosis, stroke, traumatic brain injury, and cerebrovascular lesions; Psychiatric disorders and language-cognitive dysfunction are absent.

Exclusion criteria

Exclusion criteria: 1. Aphasia with poor comprehension ability such as complete aphasia, transcortical mixed aphasia, Wernicke's aphasia, transcortical sensory aphasia, etc.; 2. Combined with other neurological diseases and other cardiopulmonary diseases that affect the function of breathing and sounding; 3. Orofacial apraxia; 4. Functional Comprehensive Assessment (FCA) language expression score of 6 points; 5. Unable to cooperate with the completion of the study.

Design outcomes

Primary

MeasureTime frame
Speech acoustic parameters;The assessment of oral motor function;Speech intelligibility, SI;

Secondary

MeasureTime frame
Frenchay Dysarthria;Diagnostic Aphasia;Mental State ;Surface electromyographic (sEMG) signals of the facial and laryngeal regions;

Countries

China

Contacts

Public ContactYing Cheng

The First Affiliated Hospital of Anhui Medical University

76356219@qq.com+86 551 6292 3256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026